Open AccessMetformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction
Author(s) -
Brian A. Bergmark,
Deepak L. Bhatt,
Darren K. McGuire,
Avivit Cahn,
Ofri Mosenzon,
Philippe Gabríel Steg,
KyungAh Im,
Estella Kanevsky,
Yared Gurmu,
Itamar Raz,
Eugene Braunwald,
Benjamin M. Scirica
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.119.040144
Subject(s) - medicine , metformin , diabetes mellitus , heart failure , cardiology , intensive care medicine , endocrinology
Metformin is first-line therapy for type 2 diabetes mellitus, although its effects on the cardiovascular system are unproved.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom